Methodist Health System: Remdesivir Offers Hope for Hospitalized COVID-19 Patients
May 08, 2020
May 08, 2020
DALLAS, Texas, May 8 -- Methodist Health System issued the following news release:
Methodist Health System is at the forefront of studying Remdesivir - an anti-viral drug that could become the "standard of care" for reducing the recovery time and severity of COVID-19 for countless patients.
In a medical trial that includes patients at Methodist Dallas Medical Center, two-thirds of the hospitalized patients in Dallas who received Remdesivir had good results - a . . .
Methodist Health System is at the forefront of studying Remdesivir - an anti-viral drug that could become the "standard of care" for reducing the recovery time and severity of COVID-19 for countless patients.
In a medical trial that includes patients at Methodist Dallas Medical Center, two-thirds of the hospitalized patients in Dallas who received Remdesivir had good results - a . . .